对神经母细胞瘤免疫疗法的当前知识和前景
Chenkai Mao1,2, Maria Poimenidou2, Brian T Craig1,2
1Department of Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Cancers
|August 29, 2024
概括
神经母细胞瘤 (NBL) 免疫疗法面临由于治疗耐药性的挑战. 基于GD2的新型疗法和组合策略显示出改善高风险NBL患者的结果的希望.
科学领域:
- 儿科瘤学 儿科瘤学
- 免疫治疗是一种免疫疗法.
- 癌症生物学 癌症生物学
背景情况:
- 神经母细胞瘤 (NBL) 细胞表现出高表达的disialoganglioside GD2,免疫治疗的目标.
- 反GD2单克隆抗体 (mAb) dinutuximab改善了NBL的结果,但复发和耐药性仍然存在.
- 目前的免疫检查点抑制剂 (ICI) 在高风险的NBL中是无效的,因为瘤微环境 (TME) 被抑制.
研究的目的:
- 审查目前的NBL治疗选择和挑战.
- 突出针对NBL采用免疫修饰疗法的局限性.
- 探索有前途的新疗法和组合免疫疗法策略.
主要方法:
- 对NBL疗法的当前文献的综述.
- 对NBL治疗耐药性的挑战进行分析.
- 识别新兴的免疫治疗方法.
主要成果:
- 迪努图西马布是关键疗法,但对于复发性/耐药性NBL.需要新的选择.
- 单剂ICI在高风险NBL中表现出有限的疗效.
- 基于GD2的疗法,纳米药物,NK细胞和CAR疗法的进展正在出现.
结论:
- 对于高风险NBL的新型,耐受性治疗非常需要.
- 组合免疫疗法策略可以克服NBL治疗耐药性.
- 新兴疗法为高风险NBL患者的护理提供了未来的希望.
更多相关视频
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
7.9K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
相关概念视频
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
